Lexicon Pharmaceuticals
LXRX
Lexicon Pharmaceuticals (LXRX) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Cantor Fitzgerald | Initiated Coverage | Overweight | $8.00 | Sep 28, 2026 |
| Citigroup | Maintained | Buy | $3.10 from $2.30 | May 11, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $6.00 | Mar 23, 2026 |
| Citigroup | Maintained | Buy | $2.30 from $2.10 | Mar 10, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $6.00 from $4.00 | Mar 5, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $4.00 | Sep 2, 2025 |
| Citigroup | Maintained | Buy | $1.90 from $1.20 | Aug 7, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $4.00 | Jun 24, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $4.00 | Mar 28, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $4.00 | Mar 7, 2025 |
| Needham | Maintained | Hold | — | Mar 7, 2025 |
| Piper Sandler | Maintained | Overweight | $6.00 from $10.00 | Mar 7, 2025 |
| Leerink Partners | Downgraded | Outperform → Market Perform | $1.00 | Mar 4, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $4.00 | Mar 3, 2025 |
| Needham | Maintained | Hold | — | Mar 3, 2025 |
| Needham | Maintained | Hold | — | Jan 29, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $4.00 | Jan 29, 2025 |
| Needham | Maintained | Hold | — | Dec 23, 2024 |
| Needham | Maintained | Hold | — | Nov 25, 2024 |
| Needham | Maintained | Hold | — | Nov 22, 2024 |
Frequently asked questions
What is the latest analyst rating on LXRX?
On Sep 28, 2026, Cantor Fitzgerald initiated coverage of Lexicon Pharmaceuticals at Overweight with a price target of $8.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.